LicianPro

INBX holders · CITADEL ADVISORS LLC 13F · INBX stock

CITADEL ADVISORS LLC Inhibrx Biosciences, Inc. (INBX) 13F holding

CITADEL ADVISORS LLC reported 33,157 INBX shares valued at $2.2M as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.

This is the newest INBX 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the INBX holders table.

INBX reports from CITADEL ADVISORS LLC · SEC Form 13F
ReportSharesValueClass
2026-03-3133,157$2.2MCOM
2025-12-3126,900$2.1MCOM
2025-09-3057,194$1.9MCOM

Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.